Variance estimation in clinical studies with interim sample size re-estimation
Related Experiment Video
Updated: Aug 17, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
1Clinical Information Science Department, AstraZeneca, S-15185 Södertälje, Sweden. frank.miller@astrazeneca.com
Abstract:
We consider clinical studies with a sample size re-estimation based on the unblinded variance estimation at some interim point of the study. Because the sample size is determined in such a flexible way, the usual variance estimator at the end of the trial is biased. We derive sharp bounds for this bias. These bounds have a quite simple form and can help for the decision if this bias is negligible for the actual study or if a correction should be done. An exact formula for the bias is also provided. We discuss possibilities to get rid of this bias or at least to reduce the bias substantially. For this purpose, we propose a certain additive correction of the bias. We see in an example that the significance level of the test can be controlled when this additive correction is used.
Related Concept Videos
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
One-Way ANOVA: Unequal Sample Sizes
One-Way ANOVA: Equal Sample Sizes
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...
Variance
Distributions to Estimate Population Parameter
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
